Welcome mark muhly | 
 |        


 
Areas of Confusion in Oncology

The complexities of cancer care encompass numerous issues that are controversial, unresolved, or problematic--areas of confusion. From time to time, ONCOLOGY will highlight such issues, with expert considerations of the relevant literature and peer-review commentaries that offer different perspectives on the topic. Send us your ideas for "areas of confusion" that we might explore in future issues (write to andrew.nash@cmpmedica.com).
 
Recent Articles

The Many Controversies of Stage IIIA/IIIB Lung Cancer
ONCOLOGY,  March 22, 2010
Further Considerations in the Treatment of Locally Advanced Lung Cancer
ONCOLOGY,  March 22, 2010

Managing the Patient With Borderline Resectable Lung Cancer


ONCOLOGY,  March 10, 2010
Changing Management Strategies for Hepatic Colorectal Metastasis
ONCOLOGY,  November 12, 2009
The Multidisciplinary Approach to Colorectal Cancer Liver Metastases
ONCOLOGY,  November 12, 2009
Managing Colorectal Cancer Liver Metastases
ONCOLOGY,  November 12, 2009
Managing a Small Recurrence in the Previously Irradiated Breast
ONCOLOGY,  October 23, 2009
Reirradiation of the Breast: Is This an Option?
ONCOLOGY,  October 13, 2009
Key Points in Repeat Breast-Conservation Therapy
ONCOLOGY,  October 13, 2009
Optimal Treatment in the Postorchiectomy Management of Clinical Stage I Seminoma
ONCOLOGY,  August 13, 2009
Showing 1 - 10 of 53 results.
Page of 6
First Previous Last
 
More Articles

The Many Controversies of Stage IIIA/IIIB Lung Cancer
ONCOLOGY,  March 22, 2010
Further Considerations in the Treatment of Locally Advanced Lung Cancer
ONCOLOGY,  March 22, 2010

Managing the Patient With Borderline Resectable Lung Cancer


ONCOLOGY,  March 10, 2010
Optimizing Endocrine Therapy in Premenopausal ER-Positive Breast Cancer Patients
ONCOLOGY,  January 26, 2009
Expanding Role of Ovarian Suppression/ Ablation in Premenopausal ER-Positive Breast Cancer: Issues and Opportunities
ONCOLOGY,  January 1, 2009
Adjuvant Endocrine Therapy for Premenopausal Hormone Receptor–Positive Breast Cancer: Much Done, More to Do
ONCOLOGY,  January 1, 2009
Challenges on the Road to Treatment Advances for Pancreatic Cancer
ONCOLOGY,  October 1, 2008
Treating Localized Pancreatic Cancer: When and How?
ONCOLOGY,  October 1, 2008
Role of Tumor Markers and Circulating Tumors Cells in the Management of Breast Cancer
ONCOLOGY,  June 1, 2008
Proof of Efficacy for Adjuvant Treatment in Stage IB NSCLC: Searching for a Needle in a Haystack?
ONCOLOGY,  April 30, 2008